New Media Department              Yu Jie, Duan Yuqing               March 19, 2021

Aomei®Omeprazole Sodium for Injection(Product specification:40mg) produced by New Time Pharmaceutical Co., LTD, a subsidiary of Lunan Pharma passed the consistency evaluation.

Omeprazole is a racemic mixture of a pair of active optically active enantiomers, which reduces gastric acid secretion through its specific action on the parietal cell proton pump, and is a special inhibitor of acid pump in the parietal cell. This product is mainly used for: ① peptic ulcer bleeding, anastomotic ulcer bleeding; (2) acute gastric mucosal injury in stress state and acute gastric mucosal injury caused by NSAIDs; (3) to prevent the stress state of severe diseases (such as cerebral hemorrhage, severe trauma, etc.) and upper gastrointestinal bleeding caused by gastric surgery; ④ as an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome when oral therapy is not available.

Omeprazole Sodium for Injection has a clear clinical positioning and is widely used. It has the same clinical efficacy and safety as the original drug, providing patients with a more economical drug option.